檢索結果 - Francesco Perrone

Refine Results
  1. 1
    Real-World Evidence in Oncology: Opportunities and Limitations

    Real-World Evidence in Oncology: Opportunities and Limitations 由 Massimo Di Maïo, Francesco Perrone, Pierfranco Conté

    出版 2019
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    The Effects of Patient-Reported Outcome Screening on the Survival of People with Cancer: A Systematic Review and Meta-Analysis

    The Effects of Patient-Reported Outcome Screening on the Survival of People with Cancer: A Systematic Review and Meta-Analysis 由 Caterina Caminiti, Giuseppe Maglietta, Francesca Diodati, Matteo Puntoni, Barbara Marcomini, Silvia Lazzarelli, Carmine Pinto, Francesco Perrone

    出版 2022
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  3. 3
    Target-based therapies in breast cancer: current status and future perspectives

    Target-based therapies in breast cancer: current status and future perspectives 由 Nicola Normanno, Alessandro Morabito, Antonella De Luca, Maria Carmela Piccirillo, Marianna Gallo, Monica R. Maiello, Francesco Perrone

    出版 2009
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  4. 4
    Individual Patient Data Meta-Analysis of Docetaxel Administered Once Every 3 Weeks Compared With Once Every Week Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer

    Individual Patient Data Meta-Analysis of Docetaxel Administered Once Every 3 Weeks Compared With Once Every Week Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer 由 Massimo Di Maïo, Francesco Perrone, Paolo Chiodini, Ciro Gallo, Carlos Camps, Wolfgang Schuette, Élisabeth Quoix, Chun-Ming Tsai, Cesare Gridelli

    出版 2007
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  5. 5
    Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer

    Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer 由 Nicola Normanno, Massimo Di Maïo, Ermelinda De Maio, Antonella De Luca, A. De Matteis, Antonio Giordano, Francesco Perrone, NULL AUTHOR_ID

    出版 2005
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  6. 6
    Angiogenesis Inhibitors in NSCLC

    Angiogenesis Inhibitors in NSCLC 由 Anna Manzo, Agnese Montanino, Guido Carillio, Raffaele Costanzo, Claudia Sandomenico, Nicola Normanno, Maria Carmela Piccirillo, Gennaro Daniele, Francesco Perrone, Gaetano Rocco, Alessandro Morabito

    出版 2017
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  7. 7
    Press releases of industry-sponsored clinical trials in oncology: characteristics, timing and financial impact

    Press releases of industry-sponsored clinical trials in oncology: characteristics, timing and financial impact 由 Anna Amela Valsecchi, Cecilia Conte, Nicola Maria Fiore, Maria Lucia Iacovino, Daniele Ierace, Letizia Galeasso, Eleonora Paganoni, Oriana Ciani, Francesco Perrone, Massimo Di Maïo

    出版 2025
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    Vandetanib (ZD6474), a Dual Inhibitor of Vascular Endothelial Growth Factor Receptor (VEGFR) and Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinases: Current Status and Future Directions

    Vandetanib (ZD6474), a Dual Inhibitor of Vascular Endothelial Growth Factor Receptor (VEGFR) and Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinases: Current Status and Future... 由 Alessandro Morabito, Maria Carmela Piccirillo, Fabiano Falasconi, Gianfranco De Feo, Antonia Del Giudice, Jane Bryce, Massimo Di Maïo, Ermelinda De Maio, Nicola Normanno, Francesco Perrone

    出版 2009
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  9. 9
    Weekly paclitaxel as first-line chemotherapy in elderly advanced breast cancer patients: a phase II study of the Gruppo Italiano di Oncologia Geriatrica (GIOGer)

    Weekly paclitaxel as first-line chemotherapy in elderly advanced breast cancer patients: a phase II study of the Gruppo Italiano di Oncologia Geriatrica (GIOGer) 由 Lucia Del Mastro, Francesco Perrone, Lazzaro Repetto, Luigi Manzione, Vittorina Zagonel, Lucia Fratino, Daniela Marenco, M. Venturini, Enrico Maggi, Claudia Bighin, T. Catzeddu, Antonella Venturino, R. Rosso

    出版 2005
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    Meta-Analysis of Single-Agent Chemotherapy Compared With Combination Chemotherapy As Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer

    Meta-Analysis of Single-Agent Chemotherapy Compared With Combination Chemotherapy As Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer 由 Massimo Di Maïo, Paolo Chiodini, Vassilis Georgoulias, Dora Hatzidaki, Koji Takeda, Floris M Wachters, Vittorio Gebbia, Egbert F. Smit, Alessandro Morabito, Ciro Gallo, Francesco Perrone, Cesare Gridelli

    出版 2009
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  11. 11
    Prognostic Relevance of Objective Response According to EASL Criteria and mRECIST Criteria in Hepatocellular Carcinoma Patients Treated with Loco-Regional Therapies: A Literature-Based Meta-Analysis

    Prognostic Relevance of Objective Response According to EASL Criteria and mRECIST Criteria in Hepatocellular Carcinoma Patients Treated with Loco-Regional Therapies: A Literature-B... 由 Bruno Vincenzi, Massimo Di Maïo, Marianna Silletta, Loretta D’Onofrio, Chiara Spoto, Maria Carmela Piccirillo, Gennaro Daniele, Francesca Comito, Eliana Maci, Giuseppe Bronte, Antonio Russo, Daniele Santini, Francesco Perrone, Giuseppe Tonini

    出版 2015
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  12. 12
    Second-Line Treatment of Advanced Non-small Cell Lung Cancer

    Second-Line Treatment of Advanced Non-small Cell Lung Cancer 由 Cesare Gridelli, Andrea Ardizzoni, Fortunato Ciardiello, Nasser H. Hanna, John V. Heymach, Francesco Perrone, Rafael Rosell, Frances A. Shepherd, Nick Thatcher, Johan Vansteenkiste, Luigi De Petris, Massimo Di Maïo, Filippo de Marinis

    出版 2008
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    Carboplatin- or Cisplatin-Based Chemotherapy in First-Line Treatment of Small-Cell Lung Cancer: The COCIS Meta-Analysis of Individual Patient Data

    Carboplatin- or Cisplatin-Based Chemotherapy in First-Line Treatment of Small-Cell Lung Cancer: The COCIS Meta-Analysis of Individual Patient Data 由 Antônio Rossi, Massimo Di Maïo, Paolo Chiodini, Robin Rudd, Hiroaki Okamoto, Dimosthenis Skarlos, Martin Früh, Wendi Qian, Tomohide Tamura, E. Samantas, Taro Shibata, Francesco Perrone, Ciro Gallo, Cesare Gridelli, Olga Martelli, Siow Ming Lee

    出版 2012
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  14. 14
    The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline

    The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline 由 Massimo Di Maïo, Ethan Basch, Fabrice Denis, Lesley Fallowfield, Patricia A. Ganz, Doris Howell, Christoph Kowalski, Francesco Perrone, Angela M. Stover, Puma Sundaresan, Lorraine Warrington, L. Zhang, Kathi Apostolidis, J. Freeman-Daily, Carla Ripamonti, Daniele Santini

    出版 2022
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    Early PET/CT Scan Is More Effective Than RECIST in Predicting Outcome of Patients with Liver Metastases from Colorectal Cancer Treated with Preoperative Chemotherapy Plus Bevacizumab

    Early PET/CT Scan Is More Effective Than RECIST in Predicting Outcome of Patients with Liver Metastases from Colorectal Cancer Treated with Preoperative Chemotherapy Plus Bevacizum... 由 Secondo Lastoria, Maria Carmela Piccirillo, Corradina Caracò, Guglielmo Nasti, Luigi Aloj, Cecilia Arrichiello, Elisabetta de Lutio di Castelguidone, Fabiana Tatangelo, Alessandro Ottaiano, Rosario Vincenzo Iaffaioli, Francesco Izzo, G. Romano, Pasqualina Giordano, Simona Signoriello, Ciro Gallo, Francesco Perrone

    出版 2013
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    A randomised clinical trial of two docetaxel regimens (weekly vs 3 week) in the second-line treatment of non-small-cell lung cancer. The DISTAL 01 study

    A randomised clinical trial of two docetaxel regimens (weekly vs 3 week) in the second-line treatment of non-small-cell lung cancer. The DISTAL 01 study 由 Cesare Gridelli, Ciro Gallo, Massimo Di Maïo, Emiddio Barletta, Anna Illiano, Paolo Maione, Stefania Salvagni, Franco Vito Piantedosi, Giovanni Palazzolo, Orazio Caffo, A. Ceribelli, Alfredo Falcone, Paola Mazzanti, L Brancaccio, Marco Alex Capuano, L. Isa, Santi Barbera, Francesco Perrone

    出版 2004
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    Pretreatment Quality of Life and Functional Status Assessment Significantly Predict Survival of Elderly Patients With Advanced Non—Small-Cell Lung Cancer Receiving Chemotherapy: A Prognostic Analysis of the Multicenter Italian Lung Cancer in the Elderly Study

    Pretreatment Quality of Life and Functional Status Assessment Significantly Predict Survival of Elderly Patients With Advanced Non—Small-Cell Lung Cancer Receiving Chemotherapy: A... 由 Paolo Maione, Francesco Perrone, Ciro Gallo, Luigi Manzione, Francovito Piantedosi, Santi Barbera, S. Cigolari, Francesco Rosetti, Elena Piazza, Sergio Robbiati, Oscar Bertetto, Silvia Novello, Maria Rita Migliorino, Adolfo Favaretto, Mario Spatafora, Francesco Ferraù, Luciano Frontini, Alessandra Bearz, Lazzaro Repetto, Cesare Gridelli

    出版 2005
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  18. 18
    Randomized Phase III Trial of Gemcitabine Plus Cisplatin Compared With Single-Agent Gemcitabine As First-Line Treatment of Patients With Advanced Pancreatic Cancer: The GIP-1 Study

    Randomized Phase III Trial of Gemcitabine Plus Cisplatin Compared With Single-Agent Gemcitabine As First-Line Treatment of Patients With Advanced Pancreatic Cancer: The GIP-1 Study 由 Giuseppe Colucci, Roberto Labianca, Francesco Di Costanzo, Vittorio Gebbia, Giacomo Cartenì, B. Massidda, E. Dapretto, Luigi Manzione, Elena Piazza, Mirella Sannicolò, Marco Ciaparrone, Luigi Cavanna, Francesco Giuliani, Evaristo Maiello, Antonio Testa, Paolo Pederzoli, Massimo Falconi, Ciro Gallo, Massimo Di Maïo, Francesco Perrone

    出版 2010
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    Prevalence and management of pain in Italian patients with advanced non-small-cell lung cancer

    Prevalence and management of pain in Italian patients with advanced non-small-cell lung cancer 由 Massimo Di Maïo, Cesare Gridelli, Ciro Gallo, Luigi Manzione, L Brancaccio, Santi Barbera, Sergio Robbiati, Giovanni Pietro Ianniello, Francesco Ferraù, E. Piazza, L. Frontini, Francesco Rosetti, Francesco Carrozza, Alessandra Bearz, Mario Spatafora, Vincenzo Adamo, L. Isa, R.V. Iaffaioli, Enrico Di Salvo, Francesco Perrone

    出版 2004
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  20. 20
    Topotecan Compared With No Therapy After Response to Surgery and Carboplatin/Paclitaxel in Patients With Ovarian Cancer: Multicenter Italian Trials in Ovarian Cancer (MITO-1) Randomized Study

    Topotecan Compared With No Therapy After Response to Surgery and Carboplatin/Paclitaxel in Patients With Ovarian Cancer: Multicenter Italian Trials in Ovarian Cancer (MITO-1) Rando... 由 Sabino De Placido, Giovanni Scambia, Giovanni Di Vagno, Emanuele Naglieri, Alessandra Lombardi, R. Biamonte, Marco Marinaccio, Giacomo Cartenì, Luigi Manzione, Antonio Febbraro, A. De Matteis, Gianpietro Gasparini, Maria Rosaria Valerio, Saverio Danese, Francesco Perrone, Rossella Lauria, Michelino De Laurentiis, Stefano Greggi, Ciro Gallo, Sandro Pignata

    出版 2004
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: